The Challenge: Understand what it takes to gain reimbursement for your digital solution offer in the EU.
A Top-10 Pharma asked LucidQuest to support them in identifying reimbursed digital health solutions in the EU and characterize the leading Pharma companies in the Digital Health space.
The Action: Primary and secondary intelligence to shortlist and understand the digital health solutions that achieved reimbursement in the EU.
LucidQuest conducted both secondary and primary intelligence to shortlist DH solutions that had achieved reimbursement in the EU and then performed deep dives into their respective business models.
We screened more than 50 Pharma and Biotech companies regarding their presence/activity in the DH space and analyzed DH-related partnerships, acquisitions, and digital solutions developed or deployed by them.
The result: A well-defined positioning of the client’s digital solution offer across the EU.
The client received a comprehensive report with 1) up-to-date insights on the DH-related activity in the EU 2) crucial information on the various business models companies employed when introducing their DH solutions to the market.
Based on our team’s report, our client was able to better position their own DH solution across key EU markets.
#digitalhealth #reimbursement #EU #pharma #top10pharma #businessstrategy #casestudy #ourwork